Ceres, which sells seeds used to produce renewable bioenergy feedstocks, lowered its IPO range to $16-$17 from $22-$24 previously. The midpoint implies a deal size 25% below that originally anticipated. Goldman Sachs and Barclays are the bookrunners on the offering.
